Use of high-intensity focused ultrasound to control bleeding  by Vaezy, Shahram et al.
We have shown recently that high-intensity
focused ultrasound (HIFU) can be used to achieve
hemostasis in two laboratory models of hemorrhage.
First, we demonstrated that in rabbits we could stop
both profuse and minor oozing bleeds from liver
incisions with HIFU application.1 Second, we
showed that in pigs we could stop moderate to pro-
fuse bleeding from major blood vessels that had
been surgically exposed and punctured.2 In the cur-
rent study, we report on a further step in the devel-
opment of acoustic hemostasis devices: mechanical
scanning HIFU for the hemostasis of large incisions
in blood vessels.
HIFU is a method of delivering large amounts of
energy to a tissue of interest. The high energy level
is possible with the following method: (1) using a
large diameter ultrasound scan transducer, (2) excit-
ing the transducer with high levels of electrical
power, and (3) focusing the ultrasound beam in a
small focal spot. In our experiments, we have used a
concave transducer, with a 3.5-cm aperture diame-
ter, and excited with approximately 50 W of electric
power. We thus have achieved an energy level of
approximately 3000 W/cm2 at the focal spot of the
ultrasound beam, which measures approximately 1
mm in lateral cross section. Such intensity levels are
about 3 to 4 orders of magnitude larger than that of
the diagnostic ultrasound scan (about 0.1 W/cm2).3
The high intensity of the ultrasound beam can easi-
ly lead to temperatures in excess of 100°C at the
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Objective: High-intensity focused ultrasound (HIFU) has been shown to be effective in
controlling hemorrhage from punctures in blood vessels. The objective of the current
study was to investigate the capability of HIFU to stop bleeding after a more severe type
of vascular injury, namely longitudinal incisions of arteries and veins.
Methods: The superficial femoral arteries, common femoral arteries, carotid arteries, and
jugular veins of four anesthetized pigs were exposed surgically. A longitudinal incision,
2 to 8 mm in length, was produced in the vessel. HIFU treatment was applied within 5
seconds of the onset of the bleeding. The HIFU probe consisted of a high-power, 3.5-
MHz, piezoelectric transducer with an ellipsoidal focal spot that was 1 mm in cross sec-
tion and 9 mm in axial dimension. The entire incision area was scanned with the HIFU
beam at a rate of 15 to 25 times/second and a linear displacement of 5 to 10 mm. A
total of 76 incisions and HIFU treatments were performed.
Results: Control of bleeding (major hemosatsis) was achieved in all 76 treatments, with
complete hemostasis achieved in 69 treatments (91%). The average treatment times of
major and complete hemostasis were 17 and 25 seconds, respectively. After the treat-
ment, 74% of the vessels in which complete hemostasis was achieved were patent with
distal blood flow and 26% were occluded. The HIFU-treated vessels showed a consistent
coagulation of the adventitia surrounding the vessels, with a remarkably localized injury
to the vessel wall. Extensive fibrin deposition at the treatment site was observed.
Conclusion: HIFU may provide a useful method of achieving hemostasis for arteries and
veins in a variety of clinical applications. (J Vasc Surg 1999;29:533-42.)
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focus after a few seconds of HIFU application.
These high temperatures can result in coagulation
necrosis of tissue and the fusion of blood vessel
walls.2 HIFU may be useful in numerous applica-
tions, including vascular surgery procedures such as
vascular anastomoses, the treatment of iatrogenic
vascular injuries, and the treatment of vascular
injuries resulting from blunt or penetrating trauma.
MATERIALS AND METHODS
Four pigs (two male and two female; age range,
3 to 5 months; weight range, 30 to 100 kg) were
used for the experiments. The procedures were per-
formed according to the guidelines of the United
States National Institute of Health for the use of lab-
oratory animals. The pigs underwent initial sedation
in the animal housing facility with an intramuscular
injection of a mixture of acepromazine maleate and
ketamine hydrochloride at a dose of 1 mg/kg and
22 mg/kg of body weight, respectively. After trans-
port to the laboratory, the animals underwent anes-
thesia with a ketamine hydrochloride/xylazine
hydrochloride mixture, 8:1 ratio, at a dose of 3.5 to
4 mL with dose to effect. The animals were intubat-
ed and kept under anesthesia with halothane, with
assisted positive pressure ventilation. The heart rate
and the oxygen saturation level were monitored
throughout the experiment.
The blood vessels of interest were exposed
(Table I). A longitudinal incision, 2 to 8 mm in
length, was made with a no. 11 scalpel. Moderate to
profuse bleeding occurred with this transmural
injury. The blood loss from the injury varied on the
basis of the incision length and the hemodynamic
condition of the animal. Bleeding rates as high as 40
mL in 10 seconds were measured by collecting the
blood in a beaker. HIFU treatment was applied
within 5 seconds of the incision by placing the tip of
the cone (focal spot of the HIFU beam, described
below) on the bleeding site (Fig 1). The treatment
protocol consisted of HIFU application for 2 to 10
seconds, followed by a visual observation to assess
whether the bleeding had stopped. Additional
HIFU treatments of a similar duration were applied
if the bleeding had not stopped. If 2 to 3 repeated
additional treatments did not result in hemostasis,
no more treatment was applied and the result was
recorded as incomplete hemostasis. All treatments
were performed with mechanical scanning of the
HIFU probe. After the completion of the treatment,
the patency of the vessel was determined by palpa-
tion. Two time points—major and complete hemo-
stasis—were recorded for each treatment. Major
hemostasis was defined as the reduction of the major
bleeding to a slow oozing (approximately 1
mL/min), and complete hemostasis was defined as the
complete arrest of bleeding. Statistical analysis of the
major and complete hemostasis times was performed
with t tests, assuming unequal variance of the popu-
lations.
The HIFU transducer characteristics are described
elsewhere.2 Briefly, the transducer for the treatment
(Sonic Concepts, Woodinville, Wash) was spherically
concave, with a focal length of 55 mm, an aperture
diameter of 35 mm, and a resonant frequency of 3.5
MHz. The half maximum beam width and length in
the focal region were 1 and 9 mm, respectively. The
driving electronics were composed of an HP 33120A
function generator (Hewlett Packard, Palo Alto,
Calif) whose output was connected to an ENI
AP400B power amplifier (ENI, Rochester, NY). A
custom-made electrical matching network was con-
nected between the amplifier and the transducer. The
HIFU transducer was equipped with a conical hous-
ing, which was made of clear plastic, with a height of
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Fig 1. Schematic drawing of high-intensity focused ultra-
sound application to a bleeding vessel. Tip of conical hous-
ing was placed on incision site, and mechanically-scanned
high-intensity focused ultrasound was applied.
Table I. Blood vessels, lumen diameter, and wall
thickness
Lumen Wall 
Blood vessel diameter (mm) thickness (mm)
Superficial femoral artery 2 ≤1
Common femoral artery 3 to 5 1 to 2
Carotid artery 4 to 6 1
Jugular vein 8 to 10 <1
50 mm and a tip opening of 3.1 mm in diameter. The
conical housing was filled with degassed water for
ultrasonic coupling from the transducer to the tissue.
The tip was covered with a polyurethane membrane.
The cone geometry allowed the center of the focal
spot of the transducer to be on the membrane.
The mechanical scanning of the HIFU probe
was used to effectively enlarge the lateral cross sec-
tion of the HIFU focal spot (approximately 1 mm
without scanning). The scanning was done with an
HP 3311A function generator (Hewlett Packard), a
PA-138 power amplifier (LabWorks, Inc, Costa
Mesa, Calif), and an ET-126B electrodynamic shak-
er (LabWorks, Inc). The frequency and amplitude of
the scanning were 15 to 25 Hz and 5 to 10 mm,
respectively. Thus, the focus of the transducer was
spread over a linear dimension equal to the ampli-
tude of the oscillations. The intensity at the focus
was in the range of 2500 to 3000 W/cm2 for all
treatments. Generally, lower intensities were used for
the treatment of moderate bleeding, and higher
intensities were used for the profuse bleeding.
Heparin was administered in all the animals at
approximately half way through the experiment at a
dose of 5,000 or 10,000 units to ensure that the ani-
mal was in an anticoagulated state. The blood clot-
ting time was measured at several time points during
the normal and anticoagulated states of the animals.
The clotting time was assessed in both an open plas-
tic dish and a closed glass tube. The clotting time of
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Fig 2. Representative sequence of photographs obtained during incision and high-intensity
focused ultrasound scan treatment of superficial femoral artery. A, Scalpel blade just before
producing longitudinal cut. B, Bleeding jet from artery. C, High-intensity focused ultrasound
scan application with conical housing. Picture of conical housing is slightly blurry because of
its vibration during high-intensity focused ultrasound scan application. D, Artery after high-
intensity focused ultrasound scan treatment and achievement of complete hemostasis. Incision
site appears as a slit. Coagulated blood was observed in incision site. Each picture is approxi-
mately 3 · 4 cm.
the heparinized blood was 2 to 10 times longer than
that of the nonheparinized blood.
Control incisions were not performed because of
the large amounts of blood loss that were observed.
However, in other experiments, seven control punc-
tures (four in femoral arteries and three in femoral
veins) were allowed to bleed for 2 minutes freely and
for 2 minutes while the HIFU applicator cone was
held on the puncture.2 The punctures continued to
bleed at the end of the 4 minutes, with a maximum
reduction in the bleeding rate of approximately 50%
to about 5 mL/min. This reduction did not meet
the definition of major hemostasis with a maximum
bleeding rate of 1 mL/min.
All the animals were alive at the end of experiment
when they were killed with an overdose of the anes-
thetic mixture, followed by a 2-mL KCl-saturated
solution within 2 minutes. Representative tissue sam-
ples were obtained from the HIFU-treated regions
and the normal regions of the blood vessels for histo-
logic examination. The tissue samples were fixed in
formalin, embedded in paraffin, and stained with
hematoxylin and eosin.
RESULTS
Fig 2 shows a representative sequence of pho-
tographs that were obtained during the incision and
the HIFU treatment of a superficial femoral artery.
The scalpel blade is shown over the artery just before
the incision was made (Fig 2A). A jet of blood
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Fig 3. Four examples of high-intensity focused ultrasound-treated regions. A, Superficial
femoral artery. Vessel was patent after treatment. Incision site (arrowhead) appears as a faint
slit. B, Superficial femoral artery. Vessel was occluded after treatment. C, Carotid artery. High-
intensity focused ultrasound-treated region appears as slightly discolored, predominantly in
dark bands (arrows) that appear in direction of mechanical scanning of high-intensity focused
ultrasound probe. Incision site (arrowhead) appears as a faint slit. D, Close-up view of high-
intensity focused ultrasound-treated region on jugular vein. Meshwork of fibers is observed at
the treatment site. All scale bars are 2 cm.
squirted from the artery after the incision (Fig 2B).
The application of HIFU, with the conical housing,
started within 5 seconds of the incision (Fig 2C).
The bleeding was completely arrested at the com-
pletion of the HIFU treatment (Fig 2D). A total of
76 incisions and HIFU treatments were performed
in this study. The heart rates and the oxygen satura-
tion levels of the animals were within normal range
throughout the experiments.
Sixty-nine of the 76 treatments resulted in the
complete cessation of bleeding (complete hemosta-
sis), and seven treatments resulted in a significant
reduction of bleeding (major hemostasis) without
complete hemostasis (incomplete hemostasis). In all
seven treatments with incomplete hemostasis, poor
targeting of the HIFU was noted as a result of either
massive bleeding and lack of visual cues for probe
positioning (four cases) or inaccessibility of the inci-
sion site in hard-to-reach regions (three cases). This
led to conditions of overexposure of the vessel, at
which point further treatment did not seem to reduce
the bleeding. In this situation, it appeared that the
vessel had become so necrosed that the vessel walls
would not fuse to close with further treatment.
Therefore, no further treatment was applied, and
clamping was used to achieve complete hemostasis.
Fig 3 shows four representative examples of
HIFU-treated vessels. Complete hemostasis was
achieved in all the vessels shown. Fig 3A shows a
superficial femoral artery with a slight discoloration of
the vessel as a result of the HIFU treatment. The
artery was patent after the treatment. A patent vessel
was observed after 51 of the 69 treatments (74%) in
which complete hemostasis was achieved. Fig 3B
shows a superficial femoral artery with severe discol-
oration and deformation after the HIFU treatment.
The treatment site was occluded after the treatment.
An occluded site was observed after 18 of 69 treat-
ments (26%). Fig 3C shows a carotid artery with the
HIFU-treated region clearly seen on the adventitia.
The adventitia was slightly discolored and hardened,
predominantly in bands (Fig 3C) that appeared to be
in the direction of the mechanical scanning of the
HIFU probe. The artery was patent after the treat-
ment. Fig 3D shows a close-up view of a jugular vein.
A tight mesh of interlacing strands was observed at
the site of the HIFU treatment. The vessel was patent
after the treatment.
Occlusion of the vessel at the treatment site (18
of 69 treatments; 26%) occurred in the superficial
femoral artery (17 cases) and in the carotid artery
(one case). The occlusion appeared to be the result
of mechanical deformation of the vessel and not of
thrombosis of the blood. In the case of the superfi-
cial femoral artery, the occlusions were within 5 cm
around the bend of the knee. In all cases, a signifi-
cant spasm of the artery was observed before incis-
ing the vessel, although considerable bleeding, in
the form of shooting jets, occurred as a result of
incision. The average major and complete hemosta-
sis times for the treatments that resulted in the
occlusion of the treatment sites were 22 and 34 sec-
onds, respectively. These values, although slightly
higher, were not significantly different from those of
the treatments that resulted in patent vessels—15
and 22 seconds, respectively. The P values of the
major and complete hemostasis times of patent ver-
sus occluded vessels were .13 and .06, respectively.
No relationship was found between either the inci-
sion length or the HIFU intensity and the occur-
rence of the occlusion.
Figs 4, 5, and 6 show the results of the histologic
analysis on three representative HIFU-treated blood
vessels in which complete hemostasis was achieved.
Fig 4 shows a superficial femoral artery with an inci-
sion (Fig 4A). A coagulated fibrin network was
observed at the incision site, with red blood cells
within the network (Fig 4B). Fig 5 shows another
example of a treated superficial femoral artery with an
incision site (Fig 5A). Abundant serous fluid was
observed in the coagulated fibrin network (Fig 5B).
Fibrin was observed at the incision site and in the ves-
sel lumen (Fig 5C). The internal elastic lamina on one
edge of the incision appeared to be in contact with the
media of the other edge of the incision. Although a
precise apposition of the incision edges was not
achieved in this case (Fig 5B), the incision was sealed
and complete hemostasis was achieved. Fig 6 shows a
carotid artery with an incision (Fig 6A). Serous fluid
was focally observed at the incision site of the vessel,
and within a well-developed fibrin network (Fig
6A,B). The vessel wall on the opposite side of the
lumen showed little or no evidence of HIFU-treat-
ment (Fig 6C). Possible effects may include: (1) a
slight denudation (Fig 6C), although no platelet
aggregation or monocytic attachment (an expected
response to denudation) were observed at the
denudation site; or (2) the presence of edema fluid
(Fig 6C), although these structures may be fat
emboli. All vessels, examined by means of light
microscopy, exhibited focal swelling of the wall at the
HIFU-treated site, without evidence of irreversible
injury.
The mean times of major and complete hemostasis
for all vessels were 17 and 25 seconds, respectively.
The range, mean, and standard deviation of the major
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and complete hemostasis times for the blood vessels in
which complete hemostasis was achieved are presented
in Table II. Complete hemostasis times, as short as 2
seconds, were noted in the jugular vein. Fig 7 shows a
plot of the mean and standard deviation of the major
and complete hemostasis times for all the HIFU-treat-
ed vessels. The hemostasis times of the common
femoral artery were the longest (28 and 46 seconds for
major and complete hemostasis, respectively), whereas
those of the jugular vein were the shortest (7 and 10
seconds for major and complete hemostasis, respec-
tively). Table III shows the results of t test compar-
isons of all the vessels. A statistically significant differ-
ence was observed for the time to control bleeding in
the small vessels as compared with the medium-sized
vessels (superficial femoral arteries compared with
common femoral arteries; Table II). The hemostasis
times of the jugular vein were significantly shorter than
the times of all the other vessels (Table II). A total of
42 incisions and HIFU treatments were performed
while the animals were heparinized. No statistically sig-
nificant differences were found between the major and
complete hemostasis times in normal and heparinized
conditions. The P values of the major and complete
hemostasis times of normal and heparinized condi-
tions were .5 and .3, respectively.
DISCUSSION
We have shown that the application of mechani-
cally scanned HIFU to blood vessel incisions, 2 to 8
mm in length, results in rapid and effective hemo-
stasis. The control of bleeding appears to be due to
a combination of tissue coagulation and fibrin depo-
sition. Fibrin may have provided a substrate for sol-
dering at the incision site, and the coagulated adven-
titia appears to have sealed the breached wall, pro-
viding extra support for the fibrin plug. The HIFU
effects on the blood vessel walls are thought to be
caused by its thermal action.2-4 A temperature rise to
approximately 70°C has been measured at the focus
of HIFU during the treatment of rabbit livers, with
HIFU intensities that were similar to those used in
the current study.1 Similar temperatures have been
measured during successful vascular coagulation and
welding with electrocoagulation 5 and laser therapy.6
At these temperatures, the alteration of the vessel
wall components (collagen, elastin, and smooth
muscle) and substrate bonding (collagen-collagen,
and collagen-elastin) is expected.7
In this study, while the use of mechanical-scan-
ning HIFU for the hemostasis of vascular incisions
was shown, several interesting observations were
made. First, a statistically significant difference was
observed for the time to control bleeding of the
small vessels as compared with the time to control
bleeding of the medium-sized vessels. Although all
the tested arteries are of muscular type, the varying
content of collagen, elastin, and smooth muscle in
these vessels8 may result in varying effects of HIFU
on the vessel. In fact, different temperature ranges
are thought to produce different effects of vascular
welding.6 Second, a statistically-significant differ-
ence was observed between the hemostasis times of
the jugular vein and all the other vessels. The thin
wall of the jugular vein seemed to be easily welded
with a short application of HIFU. The extensive
interlacing strands, observed on the jugular vein
after the HIFU treatment, and the low venous pres-
sure may have important implications for the fast
hemostasis times. Thirdly, 17 of the 18 occluded
sites occurred within 5 cm of the bend of the knee
in the superficial femoral artery while the vessel was
undergoing a spasm. The structural elasticity and the
physiologic state of a blood vessel may have signifi-
cant implications for the optimal HIFU treatment
parameters. In fact, slightly higher hemostasis times,
which bordered on statistical significance, were mea-
sured for the treatments that resulted in the occlu-
sion of the vessel, as compared with those that
resulted in a patent vessel. In general, a careful study
of the HIFU parameters, including the frequency,
the intensity, the beam pattern, and the correspond-
ing thermal action on vessel wall and its structural
components, in varying physiologic conditions, may
provide important information for the mechanism of
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Fig 4. Histologic results of representative high-intensity
focused ultrasound-treated superficial femoral artery. 
A, Cross-sectional view with incision wound (arrow). 
B, Close-up view of incision site with fibrin network
(arrow).
acoustic hemostasis of blood vessels. Finally, no dif-
ficulty was experienced in stopping bleeding in ani-
mals that had undergone treatment with heparin.
The HIFU-induced hemostasis may be independent
of normal thrombosis mechanisms.
The thermal effect of our 3.5-MHz HIFU is
quite localized. The temperature is maximal at the
focus (cross section of 1 mm), with a steep decline
of approximately 10°C/mm around the focal
spot.1,9 This temperature profile can be even steep-
er if a higher frequency HIFU or a shorter duration
excitation is used.10 Also, because of the short
HIFU excitation times, the tissue effects become
essentially perfusion independent, providing a
method of thermal delivery without significant cool-
ing between exposures. Such focal high tempera-
tures offer a potential tool for the control of bleed-
ing in small places. In the current study, however,
the mechanical scanning of HIFU was used to
obtain an effective large thermal effect to control the
bleeding of large incisions. This method may be use-
ful for the rapid hemostasis of large lacerated surface
areas of traumatized livers or spleens.
An important characteristic of HIFU is the radia-
tion pressure, which results in a net bulk flow of liq-
uid known as acoustic streaming.11 We found this
effect to be useful in the control of bleeding. The jet
of blood that squirted from the incision generally was
stopped as HIFU was applied, and the blood was
pushed back into the vessel. We believe that acoustic
streaming helped the hemostasis process by: (1) pro-
ducing a more blood-free environment in which the
visualization of the incision site was easier, (2) allow-
ing a better apposition of the incision edges because
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Fig 5. Histologic results of representative high-intensity focused ultrasound-treated superficial
femoral artery. A, Cross-sectional view of vessel with incision wound (arrow). B, Close-up view
of outer layer of vessel wall. Abundant serous fluid (arrowhead) was observed in fibrin network.
C, Fibrin was in incision slit (arrow) and in lumen of artery (black arrowhead).
Table II. Major and complete hemostasis times for high-intensity focused ultrasound treatment of surgi-
cally exposed incised blood vessels
Approximate lumen Major hemostasis time Complete hemostasis time 
Blood vessel No. of trials diameter (mm) range (s; mean ± SD) range (s; mean ± SD)
Superficial femoral artery 40 2 3 to 75 3 to 85
(16.2 ± 14.54) (24.8 ± 18.80)
Common femoral artery 7 3 to 5 15 to 40 29 to 65
(28.3 ± 9.07) (46 ± 15.26)
Carotid artery 9 4 to 6 5 to 64 11 to 64
(25.8 ± 17.03) (31.1 ± 14.94)
Jugular vein 13 8 to 10 2 to 20 2 to 30
(6.7 ± 6.03) (10.3 ± 9.48)
SD, Standard deviation.
there was no exiting blood to hold the edges open,
and (3) resulting in a more optimal deposition of
HIFU energy in the vessel wall because the blood
was pushed away from the wound site before it could
carry away much heat. The acoustic streaming mech-
anism may prove to be valuable in the treatment of
those types of hemorrhage, such as bleeding ulcers,
in which the blood flow causes difficulty in deposit-
ing the coagulative energy.12
Two important studies are necessary for the fur-
ther advancement of HIFU vascular hemostasis. First,
the optimal HIFU parameters (frequency, intensity,
and duration) must be determined for specific injuries
and blood vessels, particularly with the goal of keep-
ing the vessel patent. The determination of bursting
strength and mechanical strength of the vessel after
acoustic hemostasis will be an integral part of this
study. Second, survival animal studies in which the
HIFU treatment sites are monitored for a period after
the treatment are essential in further evaluating the
efficacy of acoustic hemostasis. Late effects will have
to be studied carefully to eliminate the possibility of
deleterious effects, such as delayed arterial rupture as
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Fig 6. Histologic results of representative high-intensity focused ultrasound-treated carotid
artery. A, Cross-sectional view of vessel with incision wound (arrow). B, Close-up view of inci-
sion. Serous fluid (arrowhead) and fibrin (arrow) were observed. C, Opposite side of lumen.
Slight denudation (arrow) and edema fluid (arrowhead) may have occurred as a result of high-
intensity focused ultrasound application.
Table III. Statistical analysis of major and com-
plete hemostasis times
Common Carotid Jugular 
femoral artery artery vein
Superficial femoral artery .012 .147 .001
.008 .295 .0007
Common femoral artery .711 .0003
.70 .0003
Carotid artery .010
.003
Results of the t test for different blood vessels. The P values for
comparison of the major (upper number) and complete (lower
number) hemostasis times are presented.
a result of possible injury to the vessel wall during the
treatment. Such a study would include a careful his-
tologic study of the vessels at the HIFU treatment site
and of the surrounding tissue. The above-mentioned
studies will have a significant effect on the clinical suc-
cess of the acoustic hemostasis.
Acoustic hemostasis may provide a valuable tool
for the surgeon, in both trauma and elective situa-
tions. The current blood vessel injury model, in
which the injury is relatively minor and the blood
vessel wall is still intact, is akin to the situation after
an iatrogenic, catheter-related vascular injury. HIFU
appears to be highly efficacious in this type of setting,
and although it was applied to surgically exposed ves-
sels in this experiment, HIFU has the capability for
percutaneous application as well. In fact, in the cur-
rent study, we used HIFU without the use of a
method to control hemorrhage (eg, clamping) to
allow the investigation of an extracorporeal applica-
tion. In most surgical situations, clamping would
perhaps provide a fast initial hemostatic mechanism,
but HIFU provides the potential of complete hemo-
stasis in the field and in surgical situations where easy
access for clamping does not exist. The average treat-
ment time for major and complete hemostasis of 17
and 25 seconds in the current model represents a sig-
nificant advantage over conventional suturing. Also,
HIFU is capable of penetrating tissue to deliver its
energy to a deep-seated region with millimeter preci-
sion and without affecting the intervening tissue,
while other hemostatic techniques, such as laser ther-
apy and electrocautery, are surface techniques and
cannot penetrate tissue or blood. The transmission of
HIFU through pools of blood during trauma surgery
may prove to be an important capability of HIFU. A
HIFU-based, acoustic hemostasis method, coupled
with an imaging method for localization, targeting,
and treatment monitoring, may have extracorporeal,
laparoscopic, and endoscopic applications.
We thank Frank Starr and Sherry Stemen for their
expert work in animal experimentation and Starr Kaplan
for her artistic illustration in Fig 1.
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